CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore

Summary

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.Singapore’s pharmaceutical market value in terms of US dollars was worth $0.7B in 2012, which increased at a CAGR of 7.4% to $1.0B in 2017. The increasing pharmaceutical market value is attributed to high life expectancy, expansion of healthcare system, developed medical infrastructure, improved patient access, and an increasing number of foreign pharmaceutical companies with a regional headquarters. Singapore’s medical devices market was valued at $2.55B in 2016, and was estimated to be $2.50B in 2019. The rapidly aging population drives demand for innovative medical technologies and therapeutic devices.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Singapore, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Novartis, Merck, GlaxoSmithKline, and Haw Par
  • Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Becton Dickinson, Baxter International, Zimmer Biomet, and Edwards Lifesciences
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Singaporean healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Singapore’s healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Singapore’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership


Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Highlights: Healthcare Start-Ups in Singapore
2.4 Key Events: Singapore Healthcare History, 2002-
2.5 Key Events: Singapore Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Singapore,
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Singapore
3.5 Pharmaceutical Market - Market Segments
3.6 COVID-19 Epidemiology, Singapore
3.7 COVID-19 Impact and Developments in Healthcare Market, Singapore
3.8 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VC, and PE Deals, Pharmaceutical Market, Singapore 2019-
7 HealthTech Landscape
7.1 HealthTech Landscape
7.1.1 HealthTech Deals Landscape, Singapore
7.2 Key HealthTech Deals, Singapore
7.3 Adoption of Technology in Healthcare, Singapore
7.4 Key Developments: Technology in Healthcare, Singapore
7.5 Regulatory Scenario Covering Use of Technology in Healthcare
7.6 HealthTech Landscape- Singapore- Benefits and Risks
8 Market Access
8.1 Overview of Healthcare System, Singapore
8.2 Reimbursement of Medicinal Products, Singapore
8.3 Overview of Public and Private Insurance Providers, Singapore
8.4 Healthcare Spending and Health Price Index, Singapore
8.5 Pricing Policies, Singapore
8.3 Regulatory Landscape, Singapore
8.3.1 Market Authorization for Pharmaceutical Drugs, Singapore
8.3.2 Market Authorization for Medical Devices, Singapore
8.3.3 Intellectual Property Rights, Patent, Singapore
8.3.4 Intellectual Property Rights, Trademark, Singapore
8.3.5 Pharmaceutical Clinical Trials Landscape, Singapore
8.3.6 Clinical Trial Regulations, Singapore
8.3.7 Exports and Imports Regulation, Singapore
8.3.8 Pharmacy Regulation, Singapore
8.3.9 Pharmaceutical Advertising Regulations, Singapore
8.3.10 Labeling and Packaging Regulations, Singapore
9 Country Healthcare Landscape
9.1 Singapore Healthcare Policy Highlights
9.2 Healthcare Facilities, Singapore
9.3 Healthcare Parameters, Singapore
9.4 Life Expectancy and Immunization Rate, Singapore
9.5 Environmental Health, Singapore
9.6 Healthcare Personnel, Singapore
9.7 Disease Burden, Singapore
9.8 Healthcare Expenditure
10 Trade Associations, Singapore
11 Trade Fairs, Singapore
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer
List of Tables
Table 1: Major Therapeutic Areas, Singapore, 2020
Table 2: COVID-19 Indicators (Number of cases), Global and Singapore, 2020
Table 3: COVID-19 Clinical Trials, Singapore, 2020
Table 4: COVID-19 Test Kits available for Diagnosis of COVID-19 , Singapore, 2020
Table 5: COVID-19 Test Kits available for Sample Collection, Singapore, 2020
Table 6: COVID-19 Test Kits available for Gene Sequencing, Singapore, 2020
Table 7: Medical Devices Market, Singapore, Revenue by Segment, 2018
Table 8: Government Healthcare Cost Subsidies, Singapore, 2020
Table 9: MediSave Allocation Rate, Singapore, 2020
Table 10: Drug Dossier Format, Singapore, 2020
Table 11: Fees for New Drug Application, Singapore, 2020
Table 12: Fees for Generic Drug Application, Singapore, 2020
Table 13: Fees for Biosimilar Application, Singapore, 2020
Table 14: General Risk Classification System, Singapore, 2020
Table 15: IVD Medical Devices Classification System, Singapore, 2020
Table 16: Fees For Medical Devices Registration, Singapore, 2020
Table 17: Patent Registration Fees, Singapore, 2020
Table 18: Trademark Registration Fees, Singapore, 2020
Table 19: Importer License Fees, Singapore
Table 20: Pharmacy License Fees, Singapore
Table 21: Label of a Pharmaceutical Unit Carton, Singapore
Table 22: Label of a Pharmaceutical Inner Label, Singapore
Table 23: Label of a Pharmaceutical Blister/Strips, Singapore
List of Figures
Figure 1: Pharmaceutical Market, Singapore, Revenue ($B), 2012-2019
Figure 2: Medical Devices Market, Singapore, Revenue ($B), 2016-2019
Figure 3: Healthcare Startups in Singapore, Singapore, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Singapore, 2019
Figure 7: Pharmaceutical Market, Singapore, Revenue ($B), 2012-2019
Figure 8: Pharmaceutical Market, Singapore, Revenue Forecast ($B), 2020-2024
Figure 9: Pharmaceutical Market, Singapore, Pharmaceutical Exports ($B), 2012-2019
Figure 10: Pharmaceutical Market, Singapore, Top Export Partners, 2019
Figure 11: Pharmaceutical Market, Singapore, Pharmaceutical Imports, ($B), 2012-2019
Figure 12: Pharmaceutical Market, Singapore, Top Import Partners, 2019
Figure 13: Pharmaceutical Market, Supply Chain, Singapore, 2020
Figure 14: Growth of Biopharmaceutical Sector, Singapore, 2020
Figure 15: List of Registered Biosimilars, Singapore, 2009-2019
Figure 16: OTC Market, Singapore, Revenue ($B), 2012-2018
Figure 17: OTC Market by Drug Category, Singapore, Revenue ($M), 2018
Figure 18: Major Therapeutic Areas, Singapore, 2020
Figure 19: COVID-19 (Number of cases), Singapore, 2020
Figure 20: COVID-19 (Number of deaths), Singapore, 2020
Figure 21: Medical Devices Market, Singapore, Revenue ($B), 2016-2019
Figure 22: Medical Devices Market, Singapore, Revenue by Segment ($M), 2018
Figure 23: Medical Devices Market, Singapore, Revenue ($B) of Major Companies, 2019
Figure 24: Deal Value and Deal Count, Pharmaceutical Market, Singapore, 2019-2020
Figure 25: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Singapore, 2019
Figure 26: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Singapore, 2019-2020
Figure 27: Pharmaceutical Market, Singapore, Top Five Therapy Areas by Deal Value ($M), 2019-2020
Figure 28: Pharmaceutical Market, Singapore, Venture Capital Financing Deals by Therapy Area, 2019-2020
Figure 29: Pharmaceutical Market, Singapore, Top Five Therapy Areas by Deal Number, 2019-2020
Figure 30: Medical Devices Market, Singapore, M&A Deals by Therapy Area, 2019-2020
Figure 31: Deal Value, HealthTech, Singapore, 2019-2020
Figure 32: Deal Count, HealthTech, Singapore, 2019-2020
Figure 33: Overview of Healthcare System, Singapore, 2020
Figure 34: MOH Organizational Structure, Singapore, 2020
Figure 35: Standard Drug List Formation, Singapore
Figure 36: Overview of Expedited Evaluation Process, Singapore, 2020
Figure 37: Overview of Full Evaluation Process, Singapore, 2020
Figure 38: Healthcare Financing, Singapore, 2020
Figure 39: Integrated Shield Plans (IPs), Singapore, 2020
Figure 40: OOP Expenditure (% of total expenditure on health), Singapore, 2012-2016
Figure 41: Annual Rate of Change (%), Health Price Index, Singapore, 2012-2019
Figure 42: HSA Organizational Structure, Singapore, 2020
Figure 43: Drug Registration Process, Singapore, 2020
Figure 44: Medical Devices Registration, Singapore, 2020
Figure 45: Patent Approval Process, Singapore, 2020
Figure 46: Trademark Approval Process, Singapore, 2020
Figure 47: Pharmaceutical Clinical Trials Count by Trial Status, Singapore, 2019-2020
Figure 48: Pharmaceutical Clinical Trials Count by Phase, Singapore, 2019-2020
Figure 49: Pharmaceutical Clinical Trials Count by Indication, Singapore, 2019-2020
Figure 50: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Singapore, 2019-2020
Figure 51: CTA-CTN Regulatory Roadmap, Singapore, 2020
Figure 52: CTC Regulatory Roadmap, Singapore, 2020
Figure 53: Hospitals by Type (number), Singapore, 2012-2018
Figure 54: Hospitals (number), Singapore, 2012-2018
Figure 55: Acute Hospital Beds (number), Singapore, 2012-2018
Figure 56: Psychiatric Hospital Beds (number), Singapore, 2012-2018
Figure 57: Community Hospital Beds (number), Singapore, 2012-2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook